Senvest Management LLC Lowers Stake in Align Technology, Inc. $ALGN

Senvest Management LLC reduced its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 4.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 699,918 shares of the medical equipment provider’s stock after selling 31,821 shares during the quarter. Align Technology accounts for approximately 4.4% of Senvest Management LLC’s holdings, making the stock its 5th biggest position. Senvest Management LLC’s holdings in Align Technology were worth $132,515,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Portside Wealth Group LLC purchased a new position in shares of Align Technology during the 2nd quarter worth $293,000. Empowered Funds LLC grew its holdings in Align Technology by 3,811.7% during the second quarter. Empowered Funds LLC now owns 50,500 shares of the medical equipment provider’s stock valued at $9,561,000 after purchasing an additional 49,209 shares during the period. Chiron Capital Management LLC bought a new position in shares of Align Technology in the second quarter worth about $208,000. Rothschild Investment LLC grew its stake in shares of Align Technology by 140.3% during the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 87 shares during the period. Finally, Nomura Asset Management Co. Ltd. increased its holdings in Align Technology by 10.1% in the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 23,618 shares of the medical equipment provider’s stock worth $4,472,000 after acquiring an additional 2,160 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $132.61 on Tuesday. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $246.19. The business’s 50 day moving average is $132.83 and its two-hundred day moving average is $158.73. The stock has a market capitalization of $9.51 billion, a P/E ratio of 25.70, a PEG ratio of 1.49 and a beta of 1.84.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.23. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The firm had revenue of $995.69 million for the quarter, compared to the consensus estimate of $980.75 million. During the same quarter in the previous year, the company posted $2.35 EPS. The company’s revenue for the quarter was up 1.8% compared to the same quarter last year. Align Technology has set its Q4 2025 guidance at EPS. As a group, equities research analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has authorized a stock repurchase program on Tuesday, August 5th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to repurchase up to 2% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Morgan Stanley increased their price objective on shares of Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. Wall Street Zen raised Align Technology from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. UBS Group dropped their price objective on Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a research note on Thursday, October 16th. Jefferies Financial Group boosted their target price on shares of Align Technology from $140.00 to $155.00 in a report on Thursday, October 30th. Finally, HSBC lifted their target price on Align Technology from $140.00 to $150.00 in a report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Align Technology presently has an average rating of “Hold” and an average target price of $175.45.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.